Main content

Donor-derived circulating cell-free DNA as a rejection biomarker and immunosuppression modulation tool in liver transplantation: A randomized controlled trial

  0
Contributors:
  2. Sudhindran S
  3. Dinesh Balakrishnan

Date created: | Last Updated:

: DOI | ARK

Creating DOI. Please wait...

Create DOI

Category: Project

Description: The study is a randomized controlled study with the primary objective to assess the efficacy of donor-derived cell-free DNA (dd-cfDNA) modulated immunosuppression in reducing acute T-cell mediated rejection following liver transplantation. Additionally, the study aims to evaluate and compare the effectiveness of dd-cfDNA as an early biomarker for detecting allograft rejection in liver transplant recipients, in contrast to conventional liver function tests.

License: CC0 1.0 Universal

Files

Files can now be accessed and managed under the Files tab.

Citation

Tags

Recent Activity

OSF does not support the use of Internet Explorer. For optimal performance, please switch to another browser.
Accept
This website relies on cookies to help provide a better user experience. By clicking Accept or continuing to use the site, you agree. For more information, see our Privacy Policy and information on cookie use.
Accept
×

Start managing your projects on the OSF today.

Free and easy to use, the Open Science Framework supports the entire research lifecycle: planning, execution, reporting, archiving, and discovery.

Copyright © 2011-2025 Center for Open Science | Terms of Use | Privacy Policy | Status | API
TOP Guidelines | Reproducibility Project: Psychology | Reproducibility Project: Cancer Biology